# Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

> **NCT02852876** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 72 (actual)

## Conditions studied

- Herpes Genitalis
- Herpes Zoster

## Interventions

- **DRUG:** ASP2151
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02852876
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02852876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02852876, "Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02852876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*